VICTORIA, BC / ACCESSWIRE / June 14, 2024 / AI/ML Innovations Inc. (the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) announced that it has entered into a shares for debt transaction with Wonderful Ventures LLC of Las Vegas, Nevada ("WV"). The Company entered into a finder's agreement dated June 7, 2024 with WV wherein WV would assist the Company in the search for a new CEO. Pursuant to the terms of the Finder's Agreement, the Company will pay CAD $67,600 to WV by a cash payment of $30,000 and the issuance of C$37,600 in Common Shares of the Company (the "Shares for Debt Transaction"). Pursuant to the Shares for Debt Transaction, the Company will issue an aggregate of 750,000 Common Shares, at a deemed price of $0.05 per Common Share. The proposed Shares for Debt Transaction is subject to the approval of the Canadian Securities Exchange.
The Common Shares issued will be subject to a four-month hold period.
About AI/ML Innovations Inc.
AI/ML Innovations Inc. has realigned its business operations to capitalize on the burgeoning fields of artificial intelligence (AI) and machine learning (ML), with an initial investment focus on emerging digital health and wellbeing companies that leverage AI, ML, cloud computing and digital platforms to drive transformative healthcare management solutions and precision support delivery across the health continuum. Through strategic partnerships with Health Gauge (95.2% owned by AIML), Tech2Heal (up to 22% ownership rights, with 12.44% currently owned by AIML), AI Rx Inc. (70% owned by AIML) and other planned accretive investments, the Company continues to capitalize on expanding growth areas, to the benefit of all the Company's stakeholders. AI/ML's shares are traded on the Canadian Securities Exchange under the symbol "AIML", the OTCQB Venture Market under "AIMLF", and the Frankfurt Stock Exchange under "42FB".
On behalf of the Board of Directors
Tim Daniels, Executive Chairman
For more information about AI/ML Innovations:
For detailed information please see AI/ML's website or the Company's filed documents at .
For further information, contact: Blake Fallis at (778) 405-0882 or info@aiml-innovations.com.
THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY ANY SECURITIES IN ANY JURISDICTION, NOR SHALL THERE BE ANY OFFER, SALE, OR SOLICITATION OF SECURITIES IN ANY STATE IN THE UNITED STATES IN WHICH SUCH OFFER, SALE, OR SOLICITATION WOULD BE UNLAWFUL.
Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE)
accepts responsibility for the adequacy or accuracy of this release.
SOURCE: AI/ML Innovations Inc.